nodes	percent_of_prediction	percent_of_DWPC	metapath
Avanafil—Balanitis—Doxorubicin—muscle cancer	0.0472	0.0472	CcSEcCtD
Avanafil—Dyspnoea exertional—Doxorubicin—muscle cancer	0.0256	0.0256	CcSEcCtD
Avanafil—Musculoskeletal pain—Vincristine—muscle cancer	0.0186	0.0186	CcSEcCtD
Avanafil—Deep vein thrombosis—Methotrexate—muscle cancer	0.0147	0.0147	CcSEcCtD
Avanafil—Pain in extremity—Vincristine—muscle cancer	0.0134	0.0134	CcSEcCtD
Avanafil—Flushing—Dactinomycin—muscle cancer	0.00961	0.00961	CcSEcCtD
Avanafil—Alanine aminotransferase increased—Etoposide—muscle cancer	0.00955	0.00955	CcSEcCtD
Avanafil—Hepatic enzyme increased—Methotrexate—muscle cancer	0.00945	0.00945	CcSEcCtD
Avanafil—Urinary tract disorder—Vincristine—muscle cancer	0.00913	0.00913	CcSEcCtD
Avanafil—Connective tissue disorder—Vincristine—muscle cancer	0.00909	0.00909	CcSEcCtD
Avanafil—Urethral disorder—Vincristine—muscle cancer	0.00907	0.00907	CcSEcCtD
Avanafil—Cardiac disorder—Vincristine—muscle cancer	0.00858	0.00858	CcSEcCtD
Avanafil—Angiopathy—Vincristine—muscle cancer	0.00839	0.00839	CcSEcCtD
Avanafil—Infestation NOS—Etoposide—muscle cancer	0.00835	0.00835	CcSEcCtD
Avanafil—Infestation—Etoposide—muscle cancer	0.00835	0.00835	CcSEcCtD
Avanafil—Mediastinal disorder—Vincristine—muscle cancer	0.00834	0.00834	CcSEcCtD
Avanafil—Blood bilirubin increased—Doxorubicin—muscle cancer	0.00818	0.00818	CcSEcCtD
Avanafil—Mental disorder—Vincristine—muscle cancer	0.0081	0.0081	CcSEcCtD
Avanafil—Musculoskeletal pain—Doxorubicin—muscle cancer	0.00783	0.00783	CcSEcCtD
Avanafil—Back pain—Vincristine—muscle cancer	0.00779	0.00779	CcSEcCtD
Avanafil—Myalgia—Dactinomycin—muscle cancer	0.00767	0.00767	CcSEcCtD
Avanafil—Influenza like illness—Doxorubicin—muscle cancer	0.00752	0.00752	CcSEcCtD
Avanafil—Diabetes mellitus—Methotrexate—muscle cancer	0.00746	0.00746	CcSEcCtD
Avanafil—Urinary tract disorder—Etoposide—muscle cancer	0.0074	0.0074	CcSEcCtD
Avanafil—Agitation—Vincristine—muscle cancer	0.0074	0.0074	CcSEcCtD
Avanafil—Urethral disorder—Etoposide—muscle cancer	0.00735	0.00735	CcSEcCtD
Avanafil—Infection—Dactinomycin—muscle cancer	0.00731	0.00731	CcSEcCtD
Avanafil—Vertigo—Vincristine—muscle cancer	0.00723	0.00723	CcSEcCtD
Avanafil—Eye disorder—Etoposide—muscle cancer	0.007	0.007	CcSEcCtD
Avanafil—Cardiac disorder—Etoposide—muscle cancer	0.00695	0.00695	CcSEcCtD
Avanafil—Flushing—Etoposide—muscle cancer	0.00695	0.00695	CcSEcCtD
Avanafil—Hypertension—Vincristine—muscle cancer	0.00695	0.00695	CcSEcCtD
Avanafil—Myalgia—Vincristine—muscle cancer	0.00686	0.00686	CcSEcCtD
Avanafil—Angiopathy—Etoposide—muscle cancer	0.0068	0.0068	CcSEcCtD
Avanafil—Immune system disorder—Etoposide—muscle cancer	0.00677	0.00677	CcSEcCtD
Avanafil—Mediastinal disorder—Etoposide—muscle cancer	0.00675	0.00675	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.0067	0.0067	CcSEcCtD
Avanafil—Infection—Vincristine—muscle cancer	0.00653	0.00653	CcSEcCtD
Avanafil—Diabetes mellitus—Doxorubicin—muscle cancer	0.00646	0.00646	CcSEcCtD
Avanafil—Nervous system disorder—Vincristine—muscle cancer	0.00644	0.00644	CcSEcCtD
Avanafil—Fatigue—Dactinomycin—muscle cancer	0.00634	0.00634	CcSEcCtD
Avanafil—Back pain—Etoposide—muscle cancer	0.00631	0.00631	CcSEcCtD
Avanafil—Muscle spasms—Etoposide—muscle cancer	0.00627	0.00627	CcSEcCtD
Avanafil—Hypotension—Vincristine—muscle cancer	0.00614	0.00614	CcSEcCtD
Avanafil—Hot flush—Doxorubicin—muscle cancer	0.00601	0.00601	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00599	0.00599	CcSEcCtD
Avanafil—Menopausal symptoms—Doxorubicin—muscle cancer	0.00595	0.00595	CcSEcCtD
Avanafil—Insomnia—Vincristine—muscle cancer	0.00594	0.00594	CcSEcCtD
Avanafil—Breast disorder—Methotrexate—muscle cancer	0.00586	0.00586	CcSEcCtD
Avanafil—Vertigo—Etoposide—muscle cancer	0.00586	0.00586	CcSEcCtD
Avanafil—Body temperature increased—Dactinomycin—muscle cancer	0.00581	0.00581	CcSEcCtD
Avanafil—Hypoglycaemia—Doxorubicin—muscle cancer	0.00576	0.00576	CcSEcCtD
Avanafil—Cough—Etoposide—muscle cancer	0.00569	0.00569	CcSEcCtD
Avanafil—Gastrointestinal disorder—Vincristine—muscle cancer	0.00567	0.00567	CcSEcCtD
Avanafil—Fatigue—Vincristine—muscle cancer	0.00567	0.00567	CcSEcCtD
Avanafil—Hypertension—Etoposide—muscle cancer	0.00563	0.00563	CcSEcCtD
Avanafil—Constipation—Vincristine—muscle cancer	0.00562	0.00562	CcSEcCtD
Avanafil—Pain in extremity—Doxorubicin—muscle cancer	0.00562	0.00562	CcSEcCtD
Avanafil—Chest pain—Etoposide—muscle cancer	0.00555	0.00555	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00551	0.00551	CcSEcCtD
Avanafil—Abdominal discomfort—Methotrexate—muscle cancer	0.00538	0.00538	CcSEcCtD
Avanafil—Infection—Etoposide—muscle cancer	0.00529	0.00529	CcSEcCtD
Avanafil—Asthenia—Dactinomycin—muscle cancer	0.00528	0.00528	CcSEcCtD
Avanafil—Blood creatinine increased—Doxorubicin—muscle cancer	0.00526	0.00526	CcSEcCtD
Avanafil—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00521	0.00521	CcSEcCtD
Avanafil—Tachycardia—Etoposide—muscle cancer	0.0052	0.0052	CcSEcCtD
Avanafil—Body temperature increased—Vincristine—muscle cancer	0.0052	0.0052	CcSEcCtD
Avanafil—Skin disorder—Etoposide—muscle cancer	0.00517	0.00517	CcSEcCtD
Avanafil—Breast disorder—Doxorubicin—muscle cancer	0.00508	0.00508	CcSEcCtD
Avanafil—Diarrhoea—Dactinomycin—muscle cancer	0.00503	0.00503	CcSEcCtD
Avanafil—Nasopharyngitis—Doxorubicin—muscle cancer	0.00502	0.00502	CcSEcCtD
Avanafil—Infestation—Methotrexate—muscle cancer	0.005	0.005	CcSEcCtD
Avanafil—Infestation NOS—Methotrexate—muscle cancer	0.005	0.005	CcSEcCtD
Avanafil—Hypotension—Etoposide—muscle cancer	0.00497	0.00497	CcSEcCtD
Avanafil—Gastritis—Doxorubicin—muscle cancer	0.00497	0.00497	CcSEcCtD
Avanafil—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00495	0.00495	CcSEcCtD
Avanafil—Influenza—Doxorubicin—muscle cancer	0.00486	0.00486	CcSEcCtD
Avanafil—Haematuria—Methotrexate—muscle cancer	0.00477	0.00477	CcSEcCtD
Avanafil—Somnolence—Etoposide—muscle cancer	0.00473	0.00473	CcSEcCtD
Avanafil—Angina pectoris—Doxorubicin—muscle cancer	0.00473	0.00473	CcSEcCtD
Avanafil—Epistaxis—Methotrexate—muscle cancer	0.00472	0.00472	CcSEcCtD
Avanafil—Asthenia—Vincristine—muscle cancer	0.00472	0.00472	CcSEcCtD
Avanafil—Vomiting—Dactinomycin—muscle cancer	0.00468	0.00468	CcSEcCtD
Avanafil—Bronchitis—Doxorubicin—muscle cancer	0.00467	0.00467	CcSEcCtD
Avanafil—Rash—Dactinomycin—muscle cancer	0.00464	0.00464	CcSEcCtD
Avanafil—Gastrointestinal disorder—Etoposide—muscle cancer	0.0046	0.0046	CcSEcCtD
Avanafil—Fatigue—Etoposide—muscle cancer	0.00459	0.00459	CcSEcCtD
Avanafil—Constipation—Etoposide—muscle cancer	0.00455	0.00455	CcSEcCtD
Avanafil—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00451	0.00451	CcSEcCtD
Avanafil—Diarrhoea—Vincristine—muscle cancer	0.0045	0.0045	CcSEcCtD
Avanafil—Pollakiuria—Doxorubicin—muscle cancer	0.00449	0.00449	CcSEcCtD
Avanafil—Urinary tract disorder—Methotrexate—muscle cancer	0.00443	0.00443	CcSEcCtD
Avanafil—Weight increased—Doxorubicin—muscle cancer	0.00442	0.00442	CcSEcCtD
Avanafil—Urethral disorder—Methotrexate—muscle cancer	0.0044	0.0044	CcSEcCtD
Avanafil—Nausea—Dactinomycin—muscle cancer	0.00437	0.00437	CcSEcCtD
Avanafil—Dizziness—Vincristine—muscle cancer	0.00435	0.00435	CcSEcCtD
Avanafil—Infestation NOS—Doxorubicin—muscle cancer	0.00433	0.00433	CcSEcCtD
Avanafil—Infestation—Doxorubicin—muscle cancer	0.00433	0.00433	CcSEcCtD
Avanafil—Body temperature increased—Etoposide—muscle cancer	0.00421	0.00421	CcSEcCtD
Avanafil—Urinary tract infection—Doxorubicin—muscle cancer	0.00421	0.00421	CcSEcCtD
Avanafil—Eye disorder—Methotrexate—muscle cancer	0.00419	0.00419	CcSEcCtD
Avanafil—Vomiting—Vincristine—muscle cancer	0.00418	0.00418	CcSEcCtD
Avanafil—Cardiac disorder—Methotrexate—muscle cancer	0.00417	0.00417	CcSEcCtD
Avanafil—Rash—Vincristine—muscle cancer	0.00414	0.00414	CcSEcCtD
Avanafil—Dermatitis—Vincristine—muscle cancer	0.00414	0.00414	CcSEcCtD
Avanafil—Haematuria—Doxorubicin—muscle cancer	0.00413	0.00413	CcSEcCtD
Avanafil—Headache—Vincristine—muscle cancer	0.00412	0.00412	CcSEcCtD
Avanafil—Epistaxis—Doxorubicin—muscle cancer	0.00408	0.00408	CcSEcCtD
Avanafil—Angiopathy—Methotrexate—muscle cancer	0.00407	0.00407	CcSEcCtD
Avanafil—Sinusitis—Doxorubicin—muscle cancer	0.00406	0.00406	CcSEcCtD
Avanafil—Immune system disorder—Methotrexate—muscle cancer	0.00405	0.00405	CcSEcCtD
Avanafil—Mediastinal disorder—Methotrexate—muscle cancer	0.00404	0.00404	CcSEcCtD
Avanafil—Mental disorder—Methotrexate—muscle cancer	0.00393	0.00393	CcSEcCtD
Avanafil—Malnutrition—Methotrexate—muscle cancer	0.00391	0.00391	CcSEcCtD
Avanafil—Nausea—Vincristine—muscle cancer	0.0039	0.0039	CcSEcCtD
Avanafil—Urinary tract disorder—Doxorubicin—muscle cancer	0.00384	0.00384	CcSEcCtD
Avanafil—Oedema peripheral—Doxorubicin—muscle cancer	0.00383	0.00383	CcSEcCtD
Avanafil—Asthenia—Etoposide—muscle cancer	0.00382	0.00382	CcSEcCtD
Avanafil—Connective tissue disorder—Doxorubicin—muscle cancer	0.00382	0.00382	CcSEcCtD
Avanafil—Urethral disorder—Doxorubicin—muscle cancer	0.00381	0.00381	CcSEcCtD
Avanafil—Back pain—Methotrexate—muscle cancer	0.00378	0.00378	CcSEcCtD
Avanafil—Pruritus—Etoposide—muscle cancer	0.00377	0.00377	CcSEcCtD
Avanafil—Vision blurred—Methotrexate—muscle cancer	0.00368	0.00368	CcSEcCtD
Avanafil—Diarrhoea—Etoposide—muscle cancer	0.00364	0.00364	CcSEcCtD
Avanafil—Eye disorder—Doxorubicin—muscle cancer	0.00363	0.00363	CcSEcCtD
Avanafil—Flushing—Doxorubicin—muscle cancer	0.00361	0.00361	CcSEcCtD
Avanafil—Cardiac disorder—Doxorubicin—muscle cancer	0.00361	0.00361	CcSEcCtD
Avanafil—Angiopathy—Doxorubicin—muscle cancer	0.00353	0.00353	CcSEcCtD
Avanafil—Dizziness—Etoposide—muscle cancer	0.00352	0.00352	CcSEcCtD
Avanafil—Immune system disorder—Doxorubicin—muscle cancer	0.00351	0.00351	CcSEcCtD
Avanafil—Vertigo—Methotrexate—muscle cancer	0.00351	0.00351	CcSEcCtD
Avanafil—Mediastinal disorder—Doxorubicin—muscle cancer	0.0035	0.0035	CcSEcCtD
Avanafil—Cough—Methotrexate—muscle cancer	0.00341	0.00341	CcSEcCtD
Avanafil—Mental disorder—Doxorubicin—muscle cancer	0.0034	0.0034	CcSEcCtD
Avanafil—Vomiting—Etoposide—muscle cancer	0.00338	0.00338	CcSEcCtD
Avanafil—Malnutrition—Doxorubicin—muscle cancer	0.00338	0.00338	CcSEcCtD
Avanafil—Rash—Etoposide—muscle cancer	0.00336	0.00336	CcSEcCtD
Avanafil—Dermatitis—Etoposide—muscle cancer	0.00335	0.00335	CcSEcCtD
Avanafil—Headache—Etoposide—muscle cancer	0.00333	0.00333	CcSEcCtD
Avanafil—Myalgia—Methotrexate—muscle cancer	0.00333	0.00333	CcSEcCtD
Avanafil—Arthralgia—Methotrexate—muscle cancer	0.00333	0.00333	CcSEcCtD
Avanafil—Chest pain—Methotrexate—muscle cancer	0.00333	0.00333	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.0033	0.0033	CcSEcCtD
Avanafil—Back pain—Doxorubicin—muscle cancer	0.00327	0.00327	CcSEcCtD
Avanafil—Muscle spasms—Doxorubicin—muscle cancer	0.00325	0.00325	CcSEcCtD
Avanafil—Vision blurred—Doxorubicin—muscle cancer	0.00319	0.00319	CcSEcCtD
Avanafil—Infection—Methotrexate—muscle cancer	0.00317	0.00317	CcSEcCtD
Avanafil—Nausea—Etoposide—muscle cancer	0.00316	0.00316	CcSEcCtD
Avanafil—Nervous system disorder—Methotrexate—muscle cancer	0.00313	0.00313	CcSEcCtD
Avanafil—Agitation—Doxorubicin—muscle cancer	0.00311	0.00311	CcSEcCtD
Avanafil—Skin disorder—Methotrexate—muscle cancer	0.0031	0.0031	CcSEcCtD
Avanafil—Vertigo—Doxorubicin—muscle cancer	0.00304	0.00304	CcSEcCtD
Avanafil—Palpitations—Doxorubicin—muscle cancer	0.00299	0.00299	CcSEcCtD
Avanafil—Hypotension—Methotrexate—muscle cancer	0.00298	0.00298	CcSEcCtD
Avanafil—Cough—Doxorubicin—muscle cancer	0.00295	0.00295	CcSEcCtD
Avanafil—Hypertension—Doxorubicin—muscle cancer	0.00292	0.00292	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00291	0.00291	CcSEcCtD
Avanafil—Insomnia—Methotrexate—muscle cancer	0.00288	0.00288	CcSEcCtD
Avanafil—Myalgia—Doxorubicin—muscle cancer	0.00288	0.00288	CcSEcCtD
Avanafil—Arthralgia—Doxorubicin—muscle cancer	0.00288	0.00288	CcSEcCtD
Avanafil—Chest pain—Doxorubicin—muscle cancer	0.00288	0.00288	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00286	0.00286	CcSEcCtD
Avanafil—Somnolence—Methotrexate—muscle cancer	0.00283	0.00283	CcSEcCtD
Avanafil—Dry mouth—Doxorubicin—muscle cancer	0.00282	0.00282	CcSEcCtD
Avanafil—Dyspepsia—Methotrexate—muscle cancer	0.00281	0.00281	CcSEcCtD
Avanafil—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00275	0.00275	CcSEcCtD
Avanafil—Fatigue—Methotrexate—muscle cancer	0.00275	0.00275	CcSEcCtD
Avanafil—Infection—Doxorubicin—muscle cancer	0.00274	0.00274	CcSEcCtD
Avanafil—Nervous system disorder—Doxorubicin—muscle cancer	0.00271	0.00271	CcSEcCtD
Avanafil—Tachycardia—Doxorubicin—muscle cancer	0.00269	0.00269	CcSEcCtD
Avanafil—Skin disorder—Doxorubicin—muscle cancer	0.00268	0.00268	CcSEcCtD
Avanafil—Hypotension—Doxorubicin—muscle cancer	0.00258	0.00258	CcSEcCtD
Avanafil—Body temperature increased—Methotrexate—muscle cancer	0.00252	0.00252	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00252	0.00252	CcSEcCtD
Avanafil—Insomnia—Doxorubicin—muscle cancer	0.0025	0.0025	CcSEcCtD
Avanafil—Somnolence—Doxorubicin—muscle cancer	0.00245	0.00245	CcSEcCtD
Avanafil—Dyspepsia—Doxorubicin—muscle cancer	0.00243	0.00243	CcSEcCtD
Avanafil—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00238	0.00238	CcSEcCtD
Avanafil—Fatigue—Doxorubicin—muscle cancer	0.00238	0.00238	CcSEcCtD
Avanafil—Constipation—Doxorubicin—muscle cancer	0.00236	0.00236	CcSEcCtD
Avanafil—Asthenia—Methotrexate—muscle cancer	0.00229	0.00229	CcSEcCtD
Avanafil—Pruritus—Methotrexate—muscle cancer	0.00226	0.00226	CcSEcCtD
Avanafil—Body temperature increased—Doxorubicin—muscle cancer	0.00218	0.00218	CcSEcCtD
Avanafil—Diarrhoea—Methotrexate—muscle cancer	0.00218	0.00218	CcSEcCtD
Avanafil—Dizziness—Methotrexate—muscle cancer	0.00211	0.00211	CcSEcCtD
Avanafil—Vomiting—Methotrexate—muscle cancer	0.00203	0.00203	CcSEcCtD
Avanafil—Rash—Methotrexate—muscle cancer	0.00201	0.00201	CcSEcCtD
Avanafil—Dermatitis—Methotrexate—muscle cancer	0.00201	0.00201	CcSEcCtD
Avanafil—Headache—Methotrexate—muscle cancer	0.002	0.002	CcSEcCtD
Avanafil—Asthenia—Doxorubicin—muscle cancer	0.00198	0.00198	CcSEcCtD
Avanafil—Pruritus—Doxorubicin—muscle cancer	0.00195	0.00195	CcSEcCtD
Avanafil—Nausea—Methotrexate—muscle cancer	0.00189	0.00189	CcSEcCtD
Avanafil—Diarrhoea—Doxorubicin—muscle cancer	0.00189	0.00189	CcSEcCtD
Avanafil—Dizziness—Doxorubicin—muscle cancer	0.00183	0.00183	CcSEcCtD
Avanafil—Vomiting—Doxorubicin—muscle cancer	0.00176	0.00176	CcSEcCtD
Avanafil—Rash—Doxorubicin—muscle cancer	0.00174	0.00174	CcSEcCtD
Avanafil—Dermatitis—Doxorubicin—muscle cancer	0.00174	0.00174	CcSEcCtD
Avanafil—Headache—Doxorubicin—muscle cancer	0.00173	0.00173	CcSEcCtD
Avanafil—Nausea—Doxorubicin—muscle cancer	0.00164	0.00164	CcSEcCtD
